Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.

Yuksel HC, Almuradova E, Buyukahiska O, Yilmaz B, Acar C, Sahin G, Tunbekici S, On S, Akar H, Sahbazlar M, Bayram E, Ergozoglu MA, Tazebay BN, Cabuk D, Kitapli S, Acikgoz Yildiz B, Yildiz S, Cosar R, Akin Telli T, Yilmaz M, Hacibekiroglu I, Sakalar T, Majidova N, Petrovska G, Celebi G, Kalender ME, Rahman M, Akosman C, Danaci Y, Nayir E, Gursoy P, Gokmen E

Open source

DOI
10.3389/fonc.2026.1756315
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1756315,
  title = {Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.},
  author = {Yuksel HC and Almuradova E and Buyukahiska O and Yilmaz B and Acar C and Sahin G and Tunbekici S and On S and Akar H and Sahbazlar M and Bayram E and Ergozoglu MA and Tazebay BN and Cabuk D and Kitapli S and Acikgoz Yildiz B and Yildiz S and Cosar R and Akin Telli T and Yilmaz M and Hacibekiroglu I and Sakalar T and Majidova N and Petrovska G and Celebi G and Kalender ME and Rahman M and Akosman C and Danaci Y and Nayir E and Gursoy P and Gokmen E},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1756315},
  url = {https://doi.org/10.3389/fonc.2026.1756315}
}

RIS

TY  - JOUR
TI  - Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.
AU  - Yuksel HC
AU  - Almuradova E
AU  - Buyukahiska O
AU  - Yilmaz B
AU  - Acar C
AU  - Sahin G
AU  - Tunbekici S
AU  - On S
AU  - Akar H
AU  - Sahbazlar M
AU  - Bayram E
AU  - Ergozoglu MA
AU  - Tazebay BN
AU  - Cabuk D
AU  - Kitapli S
AU  - Acikgoz Yildiz B
AU  - Yildiz S
AU  - Cosar R
AU  - Akin Telli T
AU  - Yilmaz M
AU  - Hacibekiroglu I
AU  - Sakalar T
AU  - Majidova N
AU  - Petrovska G
AU  - Celebi G
AU  - Kalender ME
AU  - Rahman M
AU  - Akosman C
AU  - Danaci Y
AU  - Nayir E
AU  - Gursoy P
AU  - Gokmen E
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1756315
UR  - https://doi.org/10.3389/fonc.2026.1756315
ER  - 

APA

HC, Y., E, A., O, B., B, Y., C, A., G, S., S, T., S, O., H, A., M, S., E, B., MA, E., BN, T., D, C., S, K., B, A. Y., S, Y., R, C., T, A. T., M, Y., I, H., T, S., N, M., G, P., G, C., ME, K., M, R., C, A., Y, D., E, N., P, G., & E, G. (2026). Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1756315

Source records